• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型免疫表型候选分子PD-1在慢性淋巴细胞白血病中的作用。

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.

作者信息

Grzywnowicz Maciej, Karabon Lidia, Karczmarczyk Agnieszka, Zajac Malgorzata, Skorka Katarzyna, Zaleska Joanna, Wlasiuk Paulina, Chocholska Sylwia, Tomczak Waldemar, Bojarska-Junak Agnieszka, Dmoszynska Anna, Frydecka Irena, Giannopoulos Krzysztof

机构信息

a Department of Experimental Hematooncology , Medical University of Lublin , Lublin , Poland.

b Department of Experimental Therapy , Institute of Immunology and Experimental Therapy, Polish Academy of Science , Wroclaw , Poland.

出版信息

Leuk Lymphoma. 2015;56(10):2908-13. doi: 10.3109/10428194.2015.1017820. Epub 2015 Mar 14.

DOI:10.3109/10428194.2015.1017820
PMID:25682964
Abstract

Programmed death-1 (PD-1) is a negative receptor expressed on lymphocytes including malignant B cells in chronic lymphocytic leukemia (CLL). In this work, we found that patients with CLL had a higher expression of PD-1 transcript (PDCD1) than healthy volunteers (p < 0.0001). PDCD1 expression was comparable between CLL cells from accumulation (peripheral blood) and proliferation (bone marrow) disease compartments. In blood samples of patients with mutated IGHV genes PDCD1 expression was higher than with unmutated IGHV (p = 0.0299). We demonstrated that phosphorylation of SYK and LYN, key B-cell receptor signaling kinases, was independent of PD-1 expression in patients with CLL, while ZAP-70 phosphorylation in negative tyrosine residue 292 showed strong inverse correlation (r = - 0.8, p = 0.0019). No associations between five single nucleotide polymorphisms of PDCD1, their expressions and susceptibility to CLL were found. In conclusion, PD-1 might be an independent, universal marker of CLL cells and a part of their activated phenotype, and subsequently might modulate the function of ZAP-70.

摘要

程序性死亡蛋白1(PD-1)是一种在淋巴细胞(包括慢性淋巴细胞白血病(CLL)中的恶性B细胞)上表达的负性受体。在本研究中,我们发现CLL患者的PD-1转录本(PDCD1)表达高于健康志愿者(p < 0.0001)。来自积聚(外周血)和增殖(骨髓)疾病区室的CLL细胞之间的PDCD1表达相当。在IGHV基因突变患者的血样中,PDCD1表达高于未突变IGHV的患者(p = 0.0299)。我们证明,CLL患者中关键的B细胞受体信号激酶SYK和LYN的磷酸化与PD-1表达无关,而负性酪氨酸残基292处的ZAP-70磷酸化呈强负相关(r = - 0.8,p = 0.0019)。未发现PDCD1的五个单核苷酸多态性与其表达及CLL易感性之间存在关联。总之,PD-1可能是CLL细胞的一个独立、通用的标志物及其活化表型的一部分,随后可能调节ZAP-70的功能。

相似文献

1
The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.新型免疫表型候选分子PD-1在慢性淋巴细胞白血病中的作用。
Leuk Lymphoma. 2015;56(10):2908-13. doi: 10.3109/10428194.2015.1017820. Epub 2015 Mar 14.
2
Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.慢性淋巴细胞白血病患者中 Lyn、Syk、PLCγ2 和 ERK 的表达水平,且 Lyn 水平较高与无治疗生存时间缩短相关。
Leuk Lymphoma. 2013 Jun;54(6):1165-70. doi: 10.3109/10428194.2012.736983. Epub 2012 Nov 2.
3
Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.慢性淋巴细胞白血病患者白血病细胞中 ZAP-70、磷酸化 ZAP-70 和磷酸化 Syk 的表达相关性。
Cytometry B Clin Cytom. 2010 Mar;78(2):115-22. doi: 10.1002/cyto.b.20506.
4
Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.脾酪氨酸激酶在慢性淋巴细胞白血病发病机制中的作用
Leuk Lymphoma. 2014 Dec;55(12):2699-705. doi: 10.3109/10428194.2014.891026. Epub 2014 Mar 18.
5
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.ZAP-70的表达与慢性淋巴细胞白血病中B细胞受体信号传导增加有关。
Blood. 2002 Dec 15;100(13):4609-14. doi: 10.1182/blood-2002-06-1683. Epub 2002 Aug 8.
6
Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia.程序性死亡1配体在慢性淋巴细胞白血病不同区室中的表达
Acta Haematol. 2015;134(4):255-62. doi: 10.1159/000430980.
7
Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者骨髓和外周血ZAP-70状态的流式细胞免疫表型分析比较
Cytometry B Clin Cytom. 2006 Jul 15;70(4):320-1. doi: 10.1002/cyto.b.20128.
8
Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.慢性淋巴细胞白血病中ZAP-70/Syk mRNA水平与免疫球蛋白重链基因突变状态及疾病进展的比较
Haematologica. 2005 Nov;90(11):1533-40.
9
Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.SYK 和 PLCγ2 的活性可预测慢性淋巴细胞白血病细胞对 SRC 酪氨酸激酶抑制剂 dasatinib 的凋亡反应。
Clin Cancer Res. 2010 Jan 15;16(2):587-99. doi: 10.1158/1078-0432.CCR-09-1519. Epub 2010 Jan 12.
10
The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.酪氨酸激酶Syk通过蛋白激酶Cδ(PKCδ)和蛋白酶体依赖性的Mcl-1表达调控,调节慢性淋巴细胞白血病B细胞的存活。
Oncogene. 2009 Sep 17;28(37):3261-73. doi: 10.1038/onc.2009.179. Epub 2009 Jul 6.

引用本文的文献

1
Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy.慢性淋巴细胞白血病细胞中CD69、CD49d、CD279和CD20的共表达是治疗前或治疗期间活动性疾病的一种新生物标志物。
Haematologica. 2025 Feb 1;110(2):498-503. doi: 10.3324/haematol.2024.285595.
2
Association of Polymorphisms in PD-1 and LAG-3 Genes with Acute Myeloid Leukemia.PD-1 和 LAG-3 基因多态性与急性髓系白血病的关系。
Medicina (Kaunas). 2024 Apr 26;60(5):721. doi: 10.3390/medicina60050721.
3
Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature.
小淋巴细胞淋巴瘤与肺癌并发:两例报告及文献复习。
J Clin Exp Hematop. 2023 Jun 28;63(2):132-138. doi: 10.3960/jslrt.22047. Epub 2023 May 28.
4
Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy.金属有机框架用于癌症免疫治疗的持续和靶向递送检查点抑制剂。
Sci Adv. 2021 Jan 22;7(4). doi: 10.1126/sciadv.abe7174. Print 2021 Jan.
5
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.免疫检查点分子——遗传变异作为癌症风险的标志物。
Front Immunol. 2021 Jan 14;11:606721. doi: 10.3389/fimmu.2020.606721. eCollection 2020.
6
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.慢性淋巴细胞白血病中的免疫反应功能障碍:解析分子机制和微环境条件。
Int J Mol Sci. 2020 Mar 6;21(5):1825. doi: 10.3390/ijms21051825.
7
Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia.靶向急性髓系白血病中的免疫信号检查点
J Clin Med. 2019 Feb 12;8(2):236. doi: 10.3390/jcm8020236.
8
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.PD-1 表达与 B 细胞淋巴瘤的临床 PD-1 阻断
Blood. 2018 Jan 4;131(1):68-83. doi: 10.1182/blood-2017-07-740993. Epub 2017 Nov 8.
9
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.帕博利珠单抗用于慢性淋巴细胞白血病(CLL)合并Richter转化或复发CLL患者。
Blood. 2017 Jun 29;129(26):3419-3427. doi: 10.1182/blood-2017-02-765685. Epub 2017 Apr 19.